BIOMAT Database Logo BIOMAT Database Logo

[Resistance to pyrazinamide in tuberculosis patients]. 1991

P de March Ayuela

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011718 Pyrazinamide A pyrazine that is used therapeutically as an antitubercular agent. Tisamid
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

P de March Ayuela
[Resistance to pyrazinamide in tuberculosis patients].
March 1991, Enfermedades infecciosas y microbiologia clinica,
P de March Ayuela
Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?
August 2015, Pathogens and disease,
P de March Ayuela
Pyrazinamide resistance in rifampicin discordant tuberculosis.
January 2022, PloS one,
P de March Ayuela
Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones.
January 2017, The Lancet. Infectious diseases,
P de March Ayuela
Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking.
August 2009, Bioinformation,
P de March Ayuela
Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
February 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
P de March Ayuela
Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update.
March 2016, Advances in medical sciences,
P de March Ayuela
[Research of pyrazinamide resistance of Mycobacterium tuberculosis].
October 2016, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
P de March Ayuela
Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients.
July 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
P de March Ayuela
Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
June 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Copied contents to your clipboard!